CYANOTCMedicinal Chemicals & Botanical ProductsFiscal year ends March 31

CYANOTECH CORP

Financials through Q2 FY2026, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 10, 2025

$0.70+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $5.11M
P/E (TTM): –
Dividend yield: –

CYANOTECH CORP cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2017 2017-03-31	FY 2016 2016-03-31	FY 2015 2015-03-31	FY 2014 2014-03-31	FY 2013 2013-03-31	FY 2012 2012-03-31	FY 2011 2011-03-31	FY 2010 2010-03-31
Depreciation & Amortization	1.48	1.59	1.66	1.60	1.75	1.93	1.91	1.88	1.98	1.52	1.24	1.09	0.85	0.70	0.62	0.51
Stock-Based Compensation	0.25	0.36	0.31	0.34	0.21	0.58	0.32	0.40	0.23	0.67	0.74	0.77	0.73	0.45	0.07	-0.07
Deferred Income Taxes	0	0	0	0	0	0	–	–	–	3.35	0.16	0.07	-2.12	-0.89	-0.55	–
Change in Accounts Receivable	0.14	-0.79	2.27	-1.26	-0.33	-0.17	0.68	-0.53	0.85	0.15	-0.88	1.13	-1.26	0.30	-0.63	-0.28
Change in Inventory	-0.47	3.39	-1.23	-0.72	1.24	1.62	-2.24	-1.06	-0.12	-2.15	-0.34	-1.51	-0.16	0.19	0.21	-0.94
Change in Accounts Payable	0.72	0.47	-1.42	-0.36	0.00	-2.79	1.40	-0.14	-0.33	1.04	-0.22	1.33	0.13	0.67	-0.07	0.08
Change in Unearned Revenue	-0.09	0.11	-0.08	0.04	-0.20	-0.30	0.49	0.01	0.00	–	–	–	–	–	–	–
Operating Cash Flow	-1.19	-0.46	-2.10	2.38	2.40	1.24	-0.85	1.49	1.22	0.75	1.21	2.15	1.90	5.08	1.75	1.22
Capital Expenditures	–	–	–	–	–	–	-0.43	-1.01	-0.85	-4.30	-4.18	-4.12	-3.89	-2.03	-0.51	-1.03
Investing Cash Flow	-0.25	-0.38	-1.07	-1.27	-0.76	-0.22	-0.53	-1.01	-0.85	-3.82	-3.30	-2.13	-7.25	-2.03	-0.26	-1.03
Stock Issued	0	0.39	0	0	–	–	–	–	–	–	–	–	–	0.03	0.03	0.02
Debt Issued	–	–	–	–	–	–	–	0.17	–	2.41	0.09	–	5.53	0.10	–	–
Debt Repaid	–	–	–	–	-0.67	-0.61	-0.58	-0.54	-0.50	-0.35	-0.21	-0.12	-0.64	-0.22	-0.28	-0.50
Taxes Paid on Share-Based Awards	-0.01	-0.03	-0.01	-0.05	-0.01	-0.03	-0.03	–	-0.15	–	–	–	–	–	–	–
Financing Cash Flow	0.99	0.57	1.55	-2.29	-0.29	0.56	0.82	-0.50	-0.21	2.09	0.00	-0.08	4.66	-0.05	-0.24	-0.35
Net Change in Cash	-0.45	-0.27	-1.62	-1.18	1.35	1.58	-0.55	-0.01	0.17	-0.99	–	–	–	–	–	–
Free Cash Flow	–	–	–	–	–	–	-1.28	0.49	0.37	-3.56	-2.97	-1.97	-2.00	3.05	1.23	0.19
Income Taxes Paid	0.01	0.01	0.03	0.00	0.01	–	–	–	–	0.05	0.01	0.13	0.07	0.12	0.02	0.04
Interest Paid	0.63	0.58	0.41	0.34	0.45	0.62	0.38	0.41	0.43	0.36	0.29	0.26	0.12	0.06	0.05	0.06

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Sep 30, 2025

Profitability, TTM

Gross margin: 32.0%
Operating margin: -4.2%
Net margin: -7.0%
Return on equity, FY2025: -30.9%

Financial strength

Current ratio: 1.00
Debt to equity: 1.04
Debt to assets: 34.8%
Cash to current liabilities: 5.5%

Valuation

P/E ratio: –
Price to sales: 0.20
Price to book: 0.63
Dividend yield: –